Skip to content

Recent Press Releases

Jun 18, 2009

Allergan Receives FDA Approval for OZURDEX Biodegradable, Injectable Steroid Implant with Extended Drug Release for Retinal Disease  

May 26, 2009

Allergan Receives Complete Response Letter for BOTOX(R) (Botulinum Toxin Type A) for Treatment of Upper Limb Spasticity in Adults  

May 15, 2009

VIDEO: Allergan, Inc. Announces the 'BOTOX(R) Cosmetic: Express Success' Charitable Education Campaign, Committing $250,000 to the Not-For-Profit Dress for Success  

May 1, 2009

Allergan Reports First Quarter 2009 Operating Results  

Apr 30, 2009

Allergan Comments on Today's Follow up by the U.S. Food and Drug Administration (FDA) to Its Early Communication, Concluding the Agency's Safety Review of Botulinum Toxins  

Apr 30, 2009

Allergan Comments on FDA Requested Class Labeling for Botulinum Toxin Treatments in Connection with Approval of DYSPORT(R)  

Apr 15, 2009

Video: Allergan, Inc. Marks 20 Years Since the First Approved Indications by the U.S. Food and Drug Administration for BOTOX(R) (Botulinum Toxin Type A)  

Apr 3, 2009

Allergan Announces Quarterly Conference Call  

Mar 27, 2009

Video: Allergan Announces the LATISSE(TM) Wishes Campaign, Committing $1 Million to The Make-A-Wish Foundation(R)  

Feb 4, 2009

Allergan Reports Fourth Quarter 2008 Operating Results and Announces Restructuring  

Jan 12, 2009

Allergan Announces Quarterly Conference Call  

Dec 26, 2008

Video: Allergan Announces U.S. Food and Drug Administration (FDA) Approval of Latisse(TM) -- First and Only Treatment Approved by the FDA for Hypotrichosis of Eyelashes  

Dec 26, 2008

Allergan Announces U.S. Food and Drug Administration (FDA) Approval of LATISSE™ -- First and Only Treatment Approved by the FDA for Hypotrichosis of Eyelashes  

Dec 5, 2008

FDA Advisory Committee Unanimously Recommends Approval of LATISSE(TM) (Bimatoprost Solution 0.03%) as a Treatment for Hypotrichosis of Eyelashes  

Oct 29, 2008

Allergan Reports Third Quarter 2008 Operating Results  

Oct 29, 2008

Allergan, Inc. and Spectrum Pharmaceuticals, Inc. Announce Collaboration Agreement for Apaziquone (EOquin(R)  

Oct 15, 2008

Allergan, Inc. and Clinique Announce Nationwide Availability of CLINIQUE MEDICAL  

Oct 3, 2008

Allergan Announces Quarterly Conference Call  

Sep 11, 2008

Allergan Announces Positive Top-Line Results from Phase III BOTOX(R) Headache Program  

Jul 30, 2008

Allergan Reports Second Quarter 2008 Operating Results  

Showing 1-20 of 236
Page: 1 2 3 ... 12
 Next 20